Management of Fetal Cerebroplacental Ratio < 1

General Recommendations

• The Society for Maternal‑Fetal Medicine (SMFM) advises that middle‑cerebral‑artery and cerebroplacental‑ratio Doppler should not be used for routine clinical management; surveillance should instead rely on umbilical‑artery Doppler and fetal growth assessment (GRADE 2B) 1, 2.
• International obstetric guidelines note that current evidence is insufficient to support routine use of MCA Doppler in clinical practice (no formal strength assigned) 3, 4.

Surveillance Strategies Based on Fetal Growth Status

Appropriate‑for‑Gestational‑Age Fetuses (Estimated Fetal Weight ≥ 10th percentile)

• CPR should not guide routine management decisions (SMFM) 1, 2.
• Surveillance should focus on umbilical‑artery Doppler and serial growth assessments 5, 1.
• If additional risk factors are present, perform weekly cardiotocography after fetal viability 1, 2.
• When all other parameters are normal, plan delivery at 38–39 weeks’ gestation 1, 6.

Fetal Growth Restriction (Estimated Fetal Weight < 10th percentile) – Umbilical‑Artery Doppler‑Guided Management

Normal Umbilical‑Artery Doppler (normal end‑diastolic flow)

• Repeat umbilical‑artery Doppler every 2 weeks 5, 1.
• Conduct weekly cardiotocography after viability 1, 2.
• If the fetus is between the 3rd and 10th percentile, schedule delivery at 38–39 weeks 1, 6.

Decreased End‑Diastolic Velocity (flow ratios > 95th percentile)

• Perform weekly umbilical‑artery Doppler assessments 5, 1.
• Increase cardiotocography frequency (e.g., more than weekly) 1, 2.
• Plan delivery at 37 weeks gestation 5, 1, 6.

Absent End‑Diastolic Velocity

• Conduct Doppler examinations 2–3 times per week 5, 1.
• Provide at least weekly cardiotocography, with more frequent monitoring if comorbidities arise 1, 2.
• Target delivery at 33–34 weeks gestation 5, 1, 6.

Reversed End‑Diastolic Velocity

• Admit the patient for hospitalization 5, 1.
• Administer antenatal corticosteroids (see Antenatal Interventions) 5, 1.
• Perform cardiotocography 1–2 times daily 5, 1.
• Aim for delivery at 30–32 weeks gestation 5, 1, 6.

Antenatal Interventions

• Antenatal corticosteroids should be given when delivery is anticipated before 33 weeks 6 days or between 34 weeks 0 days and 36 weeks 6 days in women at risk of delivery within 7 days (GRADE 1A) 5, 1, 6.
• Intrapartum magnesium sulfate for neuroprotection is recommended for gestations < 32 weeks (GRADE 1A) 5, 1, 6.

Delivery Timing and Mode

• For absent or reversed end‑diastolic velocity, cesarean delivery should be considered based on the overall clinical picture (GRADE 2C) 5, 1, 6.
• When fetal growth restriction is present but end‑diastolic flow is maintained, cesarean delivery is not indicated solely for growth restriction 3, 7.
• Continuous fetal monitoring during labor is recommended for all cases (no specific grade assigned) 3, 7.

Immediate Delivery of Term Fetuses with Absent Umbilical Artery End‑Diastolic Flow

Immediate Clinical Actions

• Admit the patient promptly for delivery preparation when a term fetus shows absent end‑diastolic flow, oligohydramnios, and an estimated weight of ~2.2 kg (≈3rd–5th percentile) – indicating severe growth restriction【8, 9】.
• Begin continuous electronic fetal heart‑rate monitoring to detect any signs of compromise【8】.
• Plan for cesarean delivery as the preferred mode given the high‑risk combination of absent end‑diastolic flow, oligohydramnios, and severe growth restriction【8, 9】.

Timing of Delivery

• For preterm detection of absent end‑diastolic flow, the standard recommendation is delivery at 33–34 weeks gestation【8, 9】.
• When absent end‑diastolic flow is identified at term (≥37 weeks), delivery should be performed immediately; expectant management offers no benefit and increases the risk of fetal demise【8, 9】.

Mode of Delivery Considerations

• Cesarean delivery should be strongly considered for term fetuses with absent end‑diastolic flow, oligohydramnios, and severe growth restriction because these infants have limited physiologic reserve and may not tolerate labor【8, 9】.

Clinical Rationale for Immediate Delivery

• The fetus is at immediate risk for intra‑uterine death, severe acidosis, low Apgar scores, and admission to the neonatal intensive‑care unit when delivery is delayed【8】.
• Expectant management at term is contraindicated for absent end‑diastolic flow, unlike the preterm scenario where prematurity risks must be balanced against intra‑uterine risks【8, 9】.
• Active intervention should not await spontaneous labor onset; delivery must be initiated regardless of cervical status or contractions【8, 9】.

Neonatal Preparation

• Notify the neonatal team in advance of the anticipated delivery of a growth‑restricted infant who may require resuscitation and intensive care support【8】.